Cargando…
Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by synovial inflammation and progressive joint destruction and is a primary cause of disability worldwide. Despite the existence of numerous anti-rheumatic drugs, a significant number of patients with RA do not respond...
Autores principales: | Lopez-Santalla, Mercedes, Bueren, Juan A., Garin, Marina I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237294/ https://www.ncbi.nlm.nih.gov/pubmed/34161884 http://dx.doi.org/10.1016/j.ebiom.2021.103427 |
Ejemplares similares
-
Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2020) -
Improving the Efficacy of Mesenchymal Stem/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2021) -
Assessment of mesenchymal stem/stromal cell-based therapy in K/BxN serum transfer-induced arthritis
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2022) -
Adipose‐derived mesenchymal stromal cells modulate experimental autoimmune arthritis by inducing an early regulatory innate cell signature
por: Lopez‐Santalla, Mercedes, et al.
Publicado: (2016) -
Cell Therapy With Mesenchymal Stem Cells Induces an Innate Immune Memory Response That Attenuates Experimental Colitis in the Long Term
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2020)